Cargando…
MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
Atherosclerotic cardiovascular disease remains the leading cause of morbidity and mortality worldwide. Atherosclerosis develops over several decades and is mediated by a complex interplay of cellular mechanisms that drive a chronic inflammatory milieu and cell-to-cell interactions between endothelia...
Autores principales: | Solly, Emma L., Dimasi, Catherine G., Bursill, Christina A., Psaltis, Peter J., Tan, Joanne T. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947565/ https://www.ncbi.nlm.nih.gov/pubmed/31847094 http://dx.doi.org/10.3390/jcm8122199 |
Ejemplares similares
-
The Role of miR-181c in Mechanisms of Diabetes-Impaired Angiogenesis: An Emerging Therapeutic Target for Diabetic Vascular Complications
por: Solly, Emma L., et al.
Publicado: (2021) -
Inflammation as a Therapeutic Target in Atherosclerosis
por: Nguyen, Mau T, et al.
Publicado: (2019) -
MicroRNAs as Potential Biomarkers in Atherosclerosis
por: Churov, Alexey, et al.
Publicado: (2019) -
Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer
por: Wei, Yuanyuan, et al.
Publicado: (2018) -
MicroRNAs as biomarkers in glaucoma and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2022)